Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Veit-Haibach

Showing results (151-160 of 220) with videos related to

Pageof 22
Sort By:
Plos One|June 4, 2020
The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer's diseases- A simulation study combining multi-center data and ADNI-dataTetsuro Sekine, Alfred Buck, Gaspar Delso, et al.
Clinical Nuclear Medicine|September 8, 2023
Impact of 18F-DCFPyL PET/MRI in Selecting Men With Low-/Intermediate-Risk Prostate Cancer for Focal Ablative TherapiesAdriano Basso Dias, Sangeet Ghai, Claudia Ortega, et al.
European Heart Journal|December 20, 2007
Feasibility of low-dose coronary CT angiography: first experience with prospective ECG-gatingLars Husmann, Ines Valenta, Oliver Gaemperli, et al.
Cancers|February 13, 2025
<sup>68</sup>Ga-DOTATATE PET/CT in the Initial Staging of Well-Differentiated Gastroenteropancreatic and Non-Gastroenteropancreatic Neuroendocrine Tumors: Results of a Prospective RegistryUr Metser, Roshini Kulanthaivelu, Julia Duder, et al.
Academic Radiology|August 13, 2024
Value of Dynamic Contrast-Enhanced MRI for Grade Group Prediction in Prostate Cancer: A Radiomics Pilot StudySeyed Ali Mirshahvalad, Adriano B Dias, Sangeet Ghai, et al.
Frontiers in Oncology|November 10, 2022
Prognostic value of PET/CT and MR-based baseline radiomics among patients with non-metastatic nasopharyngeal carcinomaRoshini Kulanthaivelu, Andres Kohan, Ricarda Hinzpeter, et al.
European Radiology|July 10, 2012
Combined PET/CT-perfusion in patients with head and neck cancersPatrick Veit-Haibach, Daniel Schmid, Klaus Strobel, et al.
BMC Medical Imaging|December 31, 2015
Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept studyCarsten Pietsch, Felipe de Galiza Barbosa, Martin W Hüllner, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 8, 2025
Prognostic value of early post-treatment <sup>18</sup>F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapySeyed Ali Mirshahvalad, Andres Kohan, Roshini Kulanthaivelu, et al.
Head & Neck|November 10, 2019
Evaluation of 18F-FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinomaFelipe de Galiza Barbosa, Oliver Riesterer, Stephanie Tanadini-Lang, et al.
Pageof 22

Showing results (151-160 of 220) with videos related to

Sort By:
Pageof 22
Plos One|June 4, 2020
The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer's diseases- A simulation study combining multi-center data and ADNI-dataTetsuro Sekine, Alfred Buck, Gaspar Delso, et al.
Clinical Nuclear Medicine|September 8, 2023
Impact of 18F-DCFPyL PET/MRI in Selecting Men With Low-/Intermediate-Risk Prostate Cancer for Focal Ablative TherapiesAdriano Basso Dias, Sangeet Ghai, Claudia Ortega, et al.
European Heart Journal|December 20, 2007
Feasibility of low-dose coronary CT angiography: first experience with prospective ECG-gatingLars Husmann, Ines Valenta, Oliver Gaemperli, et al.
Cancers|February 13, 2025
<sup>68</sup>Ga-DOTATATE PET/CT in the Initial Staging of Well-Differentiated Gastroenteropancreatic and Non-Gastroenteropancreatic Neuroendocrine Tumors: Results of a Prospective RegistryUr Metser, Roshini Kulanthaivelu, Julia Duder, et al.
Academic Radiology|August 13, 2024
Value of Dynamic Contrast-Enhanced MRI for Grade Group Prediction in Prostate Cancer: A Radiomics Pilot StudySeyed Ali Mirshahvalad, Adriano B Dias, Sangeet Ghai, et al.
Frontiers in Oncology|November 10, 2022
Prognostic value of PET/CT and MR-based baseline radiomics among patients with non-metastatic nasopharyngeal carcinomaRoshini Kulanthaivelu, Andres Kohan, Ricarda Hinzpeter, et al.
European Radiology|July 10, 2012
Combined PET/CT-perfusion in patients with head and neck cancersPatrick Veit-Haibach, Daniel Schmid, Klaus Strobel, et al.
BMC Medical Imaging|December 31, 2015
Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept studyCarsten Pietsch, Felipe de Galiza Barbosa, Martin W Hüllner, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 8, 2025
Prognostic value of early post-treatment <sup>18</sup>F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapySeyed Ali Mirshahvalad, Andres Kohan, Roshini Kulanthaivelu, et al.
Head & Neck|November 10, 2019
Evaluation of 18F-FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinomaFelipe de Galiza Barbosa, Oliver Riesterer, Stephanie Tanadini-Lang, et al.
Pageof 22